Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive conditional clearance from the European Union for its almost $7 billion takeover of U.S. specialty drugmaker Cephalon Inc. (CEPH), Reuters reported Monday citing a person with direct knowledge of the matter.

The EU executive, which is scheduled to decide by Oct. 13 whether to clear the acquisition, wasn't immediately available for comment, Reuters said.

Full story at http://www.reuters.com/article/2011/10/10/us-cephalon-teva-eu-idUSTRE7993OH20111010

-Dow Jones Newswires; 212-416-2900

Cephalon (NASDAQ:CEPH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Cephalon
Cephalon (NASDAQ:CEPH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Cephalon